Muslim youth slapped during protest against Amarnath terror attack

Mangaluru, May 18: The coastal city of Mangaluru and other parts of twin districts of Dakshina Kannada and Udupi are receiving heavy rain coupled with lightning and thunder.

The rain, which started in the wee hours, continued to lash for hours. It brought much relief from the sweltering heat.

Waterlogged roads in different parts of Mangaluru cause inconvenience to motorists. The clouds were so dark that the drivers were forced to switch on the headlights while driving vehicles in the morning.

The IMD has predicted heavy rain in the coastal Karnataka for next two days.

Lighting claims a life

Meanwhile, a youth died after lightning struck him at Paduyenagudde in Katpadi of Udupi district on Sunday late night. The deceased was identified as Bharat. Though he was rushed to the hospital, he failed to respond to the treatment.

Mangaluru, Mar 23: As many as 600 people who arrived from foreign countries are under the surveillance of the district police in the Dakshina Kannada, as a measure to contain the spread of Covid-19, said Superintendent of Police B M Laxmi Prasad on Monday.

The police personnel are visiting their houses in Dakshina Kannada police jurisdiction. They have been asked to remain quarantined at home for 14 days."We have appealed to the local residents to tip the police if they violate the quarantine period,"he added.

Talking to newsmen here, he said that all the roads in border areas connecting Kerala had been closed, the police have strengthened security in border areas. Please log in to get detailed story.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.